Correction: NCSTN promotes hepatocellular carcinoma cell growth and metastasis via β-catenin activation in a Notch1/AKT dependent manner

Correction: J Exp Clin Cancer Res 39, 128 (2020)

https://doi.org/10.1186/s13046-020-01638-3

Following publication of the original article [1], author identified an error in Fig. 2, specifically:

• Figure 2h - the cell migration assay of Hep3B-Vector group

Fig. 2.

NCSTN promotes HCC cell growth and metastasis in vitro. a The effects of NCSTN knockdown and overexpression were examined by western blotting analysis in HCCLM3 and Hep3B cells. Loading control was assessed by β-actin. b CCK8 assays showed NCSTN depletion inhibited cell growth of HCCLM3 and NCSTN overexpression promoted cell growth of Hep3B. c, d Colony formation assays showed colony numbers in HCC cells with NCSTN depletion or overexpression. e, f The cell cycle assays showed that NCSTN depletion increased the G0/G1 fraction and decreased the S and G2/M fraction in HCCLM3 cells, whereas NCSTN overexpression decreased the G0/G1 fraction and increased the S and G2/M fraction in Hep3B cells. g, h The migration and invasion capacity was determined in the indicated HCC cells. Scale bar, 100 μm. i, j Wound healing assays showed the migration capacity of indicated HCC cells. Scale bar, 100 μm. HCC, hepatocellular carcinoma; CCK8, cell counting kit-8. *p < 0.05, **p < 0.01, ***p < 0.001

The correct figure is presented below:

This correction does not change the result, interpretation, and conclusions of the study. The original article has been corrected.